NATURLAND Stock Overview

Manufactures and sells pharmaceutical products in Hungary. More details

NATURLAND fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	3/6
Financial Health	5/6
Dividends	0/6

Rewards

Revenue grew by 8.2% over the past year

Risk Analysis

Shares are highly illiquid

Less than 3 years of financial data is available

Community vs My Fair Value

Create Narrative

Select a narrative for quick price alerts from the community, or create your own.

NATURLAND Holding Vagyonkezelo es Befektetesi Nyilvanosan Mukodo Reszvenytarsasag Competitors

Price History & Performance

Summary of share price highs, lows and changes for NATURLAND Holding Vagyonkezelo es Befektetesi Nyilvanosan Mukodo Reszvenytarsasag
Historical stock prices
Current Share Price	Ft2,580.00
52 Week High	Ft2,620.00
52 Week Low	Ft2,360.00
Beta	1.92
1 Month Change	0%
3 Month Change	3.20%
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	145.71%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

	NATURLAND	HU Pharmaceuticals	HU Market
7D	0%	2.5%	1.7%
1Y	n/a	-18.5%	28.3%

Return vs Industry: Insufficient data to determine how NATURLAND performed against the Hungarian Pharmaceuticals industry.

Return vs Market: Insufficient data to determine how NATURLAND performed against the Hungarian Market.

Price Volatility

Is NATURLAND's price volatile compared to industry and market?
NATURLAND volatility
NATURLAND Average Weekly Movement	n/a
Pharmaceuticals Industry Average Movement	6.0%
Market Average Movement	5.4%
10% most volatile stocks in HU Market	8.1%
10% least volatile stocks in HU Market	3.4%

Stable Share Price: NATURLAND's share price has been volatile over the past 3 months compared to the Hungarian market.

Volatility Over Time: Insufficient data to determine NATURLAND's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
2012	157	Emil Sántó	naturlandholding.hu

NATURLAND Holding Vagyonkezelo es Befektetesi Nyilvanosan Mukodo Reszvenytarsasag manufactures and sells pharmaceutical products in Hungary. It sells its products under the Naturland brand name. The company was founded in 2012 and is based in Budapest, Hungary.

NATURLAND Holding Vagyonkezelo es Befektetesi Nyilvanosan Mukodo Reszvenytarsasag Fundamentals Summary

How do NATURLAND Holding Vagyonkezelo es Befektetesi Nyilvanosan Mukodo Reszvenytarsasag's earnings and revenue compare to its market cap?
NATURLAND fundamental statistics
Market cap	Ft35.65b
Earnings (TTM)	Ft1.42b
Revenue (TTM)	Ft6.15b

25.1x

P/E Ratio

5.8x

P/S Ratio

Is NATURLAND overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
NATURLAND income statement (TTM)
Revenue	Ft6.15b
Cost of Revenue	Ft3.71b
Gross Profit	Ft2.44b
Other Expenses	Ft1.02b
Earnings	Ft1.42b

Last Reported Earnings

Dec 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)	102.81
Gross Margin	39.68%
Net Profit Margin	23.10%
Debt/Equity Ratio	10.2%

How did NATURLAND perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/05/21 22:50
End of Day Share Price	2025/05/05 00:00
Earnings	2024/12/31
Annual Earnings	2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

NATURLAND Holding Vagyonkezelo es Befektetesi Nyilvanosan Mukodo Reszvenytarsasag is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.